Biomarker Testing in Advanced NSCLC: A Pathology Perspective
Chung-Che (Jeff) Chang, MD, PhD
Medical Director,
Hematology and Molecular Pathology Labs,
Florida Hospital Cancer Institute,
Orlando, Florida
Dr. Chang discusses how to improve biomarker testing success rates in NSCLC through optimizing sample selection and instituting protocols that reduce front-end turnaround time
CASE STUDY ON BIOMARKER TESTING IN ADVANCED NSCLC
Case Study
Patient Case: Biomarker Testing in Advanced NSCLC
Chung-Che (Jeff) Chang, MD, PhD
A Case-Based Pathology Perspective on Biomarker Testing in NSCLC
Gaetane C. Michaud, MD
A Case-Based Pulmonology Perspective on Biomarker Testing in NSCLC
Mark A. Socinski, MD
A Case-Based Oncology Perspective on Biomarker Testing in NSCLC
IN ADVANCED NSCLC
Chung-Chee (Jeff) Chang, MD, PhD
A Pathology Perspective on Biomarker Testing in NSCLC
Martin Dietrich, MD, PhD
A Community Oncology Perspective on Biomarker Testing in NSCLC
Gaetane C. Michaud, MD
A Pulmonology Perspective on Biomarker Testing in NSCLC
Mark A. Socinski, MD
An Oncology Perspective on Biomarker Testing in NSCLC
